OCTAGON CAPITAL ADVISORS LP – Stoke Therapeutics, Inc. Transaction History
OCTAGON CAPITAL ADVISORS LP portfolio value:
$9.80M
portfolio value
OCTAGON CAPITAL ADVISORS LP quarter portfolio value change:
-2.80%
quarter
Stoke Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | -282K | $12.84 | 763.45K | |
| Q2 2022 | share | Decrease | -6.15% | -50K shares | -7.03M | $13.21 | 763.45K |
| Q1 2022 | share | Increase | +3.79% | 29.68K shares | -1.68M | $21.05 | 813.45K |
| Q4 2021 | share | Increase | +164.05% | 486.94K shares | 11.25M | $24.07 | 783.76K |
| Q3 2021 | share | 0.00% | 0 shares | -2.44M | $25.44 | 296.82K | |
| Q2 2021 | share | Increase | 0.00% | 296.82K shares | 9.99M | $33.66 | 296.82K |